Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine-Paclitaxel 3-Weekly in Metastatic Breast Cancer
NCT00316199Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in breast cancer, sponsored by Eli Lilly and Company. Started Apr 2006; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00316199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316199.